Explore more publications!

Massachusetts Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.

Press releases published on December 17, 2025

The Ukrainian Book Challenge: One Book, One Act of Solidarity
New ATS Heat Sinks Designed for NVIDIA Jetson Thor Modules
SATENA Airlines Achieves 17% Passenger Growth and Expands Regional Connectivity Across 28 Departments of Colombia
Workbar Announces Major Expansion of Its High-Performing Needham Location
Censinet Launches AI Governance, Risk, and Compliance Webinar Series
Joined Bio Launches its Referral Program, Expanding Access and Earnings for its Participants
Aspen Aerogels Announces Amendment to MidCap Credit Facility
RZLT: Rezolute, Inc. Investigated for Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm
Fermi Inc. Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm’s Investigation
Immuneering Advances Towards Dosing First Patient in Phase 3 Atebimetinib Trial for First-Line Metastatic Pancreatic Cancer Patients, Securing Alignment with FDA and EMA
RealMapInfo LLC Provides Comprehensive Residential Property Survey
AI in Automotive Market to Grow 27.5% Annually Through 2030
UPDATE --  Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates via Webcast
HAProxy Technologies Announces Availability of HAProxy Community Performance Packages Compiled with AWS-LC
Driving Innovation and Scale: Thrive Targets $1 Billion Market Position
Avalyn to Present at the 44th Annual J.P. Morgan Healthcare Conference
The 2026 State of Performance Marketing Report: How Inflated Signals, AI Noise, and Disconnected Tools Are Derailing B2B Growth
Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates
Compass Therapeutics to Participate in the J.P. Morgan 2026 Healthcare Conference
Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions